SELE and acute myeloid leukemia: This analysis confirmed that absence or blockade of E-selectin reduced the proportion of quiescent AML blasts (in G0 phase of cell cycle) by ~25% compared to saline-vehicle injected wildtype host controls (Fig. 4b, left panel).